Protective mechanisms by omega-6 lipids in experimental autoimmune encephalomyelitis (EAE) are associated with cytokines and eicosanoids.
Harbige
L S
LS
Department of Immunology, Rayne Institute, UMDS, St Thomas Hospital, London, UK.
Layward
L
L
Morris
M
M
Amor
S
S
D000284:Administration, Oral; D000818:Animals; D002478:Cells, Cultured; D004042:Dietary Fats, Unsaturated / Q000008:administration & dosage / Q000627:therapeutic use; D015232:Dinoprostone / Q000378:metabolism; D004681:Encephalomyelitis, Autoimmune, Experimental / Q000276:immunology* / Q000473:pathology / Q000517:prevention & control*; D043371:Fatty Acids, Omega-6; D005231:Fatty Acids, Unsaturated / Q000008:administration & dosage / Q000627:therapeutic use*; D008213:Lymphocyte Activation; D051379:Mice; D008815:Mice, Inbred Strains; D010938:Plant Oils / Q000008:administration & dosage / Q000627:therapeutic use*; D010944:Plants; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology*; D016212:Transforming Growth Factor beta / Q000096:biosynthesis; D017965:gamma-Linolenic Acid
D004042:Dietary Fats, Unsaturated; D043371:Fatty Acids, Omega-6; D005231:Fatty Acids, Unsaturated; D010938:Plant Oils; D016212:Transforming Growth Factor beta; D017965:gamma-Linolenic Acid; C079363:borage oil; D015232:Dinoprostone